IL17A and rheumatoid arthritis: Recent reports of local effector cells in joints of established RA have provided first evidence that innate immune cells, particularly mast cells may serve as another major source of IL-17A in RA and contribute to pro-inflammatory effector responses in the arthritic synovium [30,40].